Rubella outbreak on Tokunoshima Island in 2004: Serological and epidemiological analysis of pregnant women with rubella

Journal of Obstetrics and Gynaecology Research

Volumn 32, Issue 5, 2006, Pages 461-467

  Kaneko, Masatoki ^a,d   Sameshima, Hiroshi ^a   Ikenoue, Tsuyomu ^a   Minematsu, Toshio ^b   Kusumoto, Kazumi ^b   Ibara, Satoshi ^c   Kamitomo, Masato ^c   Maruyama, Yuko ^c  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b Aisenkai Nichinan Hospital   (Japan)

^c Kagoshima City Hospital   (Japan)

^d UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Congenital rubella syndrome; Revised immunization law; Rubella outbreak; Rubella vaccine; Sentinel system

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; RUBELLA ANTIBODY; RUBELLA VACCINE;

ADULT; ANAMNESIS; ANTIBODY TITER; ARTICLE; BACTERIAL IMMUNITY; CLINICAL ARTICLE; CONGENITAL RUBELLA SYNDROME; CONTROLLED STUDY; DELIVERY; EPIDEMIC; EPIDEMIOLOGICAL DATA; ERADICATION THERAPY; FAMILY; FEMALE; HIGH RISK POPULATION; HIGH RISK PREGNANCY; HUMAN; IMMUNIZATION; INFECTION RISK; INTERVIEW; JAPAN; NEWBORN; OBSTETRICS; PREGNANCY; PREGNANT WOMAN; PREVENTIVE HEALTH SERVICE; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RUBELLA; SEROLOGY; UMBILICAL CORD BLOOD; URINALYSIS; URINE; VIRUS DETECTION; VIRUS GENOME; VIRUS IMMUNITY;

ADULT; ANTIBODIES, VIRAL; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN M; INFANT, NEWBORN; JAPAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; RUBELLA; RUBELLA VACCINE; RUBELLA VIRUS;

EID: 33748776803     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2006.00445.x     Document Type: Article

References (20)

1. Katow S. Surveillance of congenital rubella syndrome in Japan, 1978-2002: effect of revision of the immunization law. Vaccine 2004; 22: 4084-4091.
2. Bosma TJ, Corbett KM, O'shea S, Banatvala JE, Best JM. PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol 1995; 33: 1075-1079.
3. Terada K. Rubella and congenital rubella syndrome in Japan: epidemiological problems. Jpn J Infect Dis 2003; 56: 81-87.
4. National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare. Rubella, Japan, 1999-2002. Infect. Agents Surveill Rep 2003; 24: 53-58 (in Japanese).
5. Isomura S, Tsunoda K, Miyazaki M. Effective practice of immunization program. Annual Committee Reports on Effective Practice of Immunization Program and Adverse Effect of Vaccines. Tokyo: Vaccine Research Center, 2001. (in Japanese).
6. Aiboshi S. Infectious disease weekly report Japan. Ministry of health, labour and welfare. National Institute of Infectious Diseases, IDWR 2004; 6 (17): 7-9 (in Japanese).
7. Hinman AR, Irons B, Lewis M, Kandola K. Economic analysis of rubella and rubella vaccines: a global review. Bull World Health Organ 2002; 80: 264-270.
8. Vaccine Assessment and Monitoring Team. Twelve Conclusions and Recommendations. Report of a meeting on preventing congenital rubella syndrome. immunization strategies, surveillance needs. Department of Vaccines and Biologicals, WHO, Geneva, 2000 January 12-14.
9. Maldonado Y. Rubella. P.951. In: Behrman RE, Kliegman RM, Jenson HB (eds). Nelson Textbook of Pediatrics, 16th edn. Philadelphia: Saunders, 2000; 951-953.
10. Weber B, Enders G, Schlosser R et al. Congenital rubella syndrome after maternal reinfection. Infection 1993; 21: 118-121.
11. Best JM, Banatvala JE, Morgan-Capner P, Miller E. Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. Br Med J 1989; 299: 773-775.
12. Ushida M, Katow S, Furukawa S. Congenital rubella syndrome due to infection after maternal antibody conversion with vaccine. Jpn J Infect Dis 2003; 56: 68-69.
13. Plotkin SA, Buser F. History of RA 27/3 rubella vaccine. Rev Infect Dis 1985; 7: S77-S78.
14. Christenson B, Bottiger M. Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults. Vaccine 1994; 12: 41-45.
15. Takahashi A, Ueda K, Hidaka Y, Miyazaki C, Tanaka Y, Nishima S. Twenty-three-year follow-up study of rubella antibodies after immunization in a closed population, and serological response to revaccination. Vaccine 1997; 16: 1791-1795.
16. Committee on Infectious Diseases. American academy of pediatrics. Measles: reassessment of the current immunization policy. Pediatrics 1989; 84: 110-112.
17. Beckler N, Rouderfer V. Simultaneous control of measles and rubella by multidose vaccination schedules. Math Biosc 1996; 131: 81-102.
18. Peltola H, Heinonen O, Paunio M. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med 1994; 331: 1397-1402.
19. Murakami Y, Hashimoto S, Taniguchi K, Osaka K, Fuchigami H, Nagai M. Evaluation of a method for issuing warnings pre-epidemics and epidemics in Japan by infectious diseases surveillance. J Epidemiol 2004; 14: 33-40.
20. Plotkin SA. Rubella eradication. Vaccine 2001; 19: 3311-3319.